Quoin Pharmaceuticals (QNRX) announced recent corporate accomplishments and provided an update on its fourth quarter and full-year 2024 ...

Fourth Quarter 2024 Highlights On Dec. 20, 2024, Quoin announced the successful completion of a $6.8 million public offering, bolstering the company’s financial position to support ongoing clinical ...

Quoin Pharmaceuticals (NASDAQ:QNRX – Get Free Report) is anticipated to post its quarterly earnings results before the market ...

ASHBURN, Va., March 04, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty ...

对Cellect Biotechnology ADR来说，这是充满挑战的一年。该公司股票QNRX已跌至52周新低，仅为0.28美元，市值仅为624万美元。根据 InvestingPro 分析，该股票目前的交易价格低于其公允价值，尽管出现下跌，但可能存在投资机会。这一显著下跌反映了该生物科技公司的整体趋势，过去一年股价下跌了81.13%。该公司贝塔系数为1.59，流动比率为3.02，显示出较高的波动 ...

Quoin Pharmaceuticals announced promising clinical results from its ongoing study of QRX003 for treating Pediatric Netherton Syndrome. In just two weeks of whole-body application, significant ...

Quoin Pharmaceuticals Ltd. has announced the filing of U.S. and International patent applications for new topical formulations of rapamycin aimed at treating rare diseases such as microcystic ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ASHBURN, Va., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage specialty pharmaceutical company focused on rare ...

Du Quoin State Fair manager Luke Davison says “Our Grandstand lineup features something for everyone - from music to car and harness racing. We’re ready for the best 11 days of summer.” Tickets will ...